ID93+GLA-SE Vaccine Against Tuberculosis in Older Adults Aged 55-74
ID93+GLA-SE Vaccine Against Tuberculosis in Older Adults Aged 55-74
Recruiting · NCT06714513 · Registry updated 2025-06-17Clinical trials
Swipe the table sideways for more columns.
| Trial | Conditions | Status | Phase | Updated | More info | NCT ID |
|---|---|---|---|---|---|---|
| ID93+GLA-SE Vaccine Against Tuberculosis in Older Adults Aged 55-74 | Actinomycetales infectious disease, Bacterial Infections and Mycoses, Infections, bacterial infectious disease, gram-positive bacterial infections, lung disorder, mycobacterial infectious disease, pulmonary tuberculosis, respiratory system disorder, respiratory tract infectious disorder, tuberculosis | Recruiting | Phase 1 | 2025-06-17 | NCT06714513 |
1 results · Page 1 of 1
Organizations
Swipe the table sideways for more columns.
| Organizations | Linked trials |
|---|---|
| Quratis Inc. | 1 |
4 results · Page 1 of 1
Research sites
Swipe the table sideways for more columns.
| Research sites | City | Country | Linked trials |
|---|---|---|---|
| Ajou University Hospital | Suwon | South Korea | 40 |
| Chung-Ang University Gwangmyeong Hospital | Gwangmyeong | South Korea | 2 |
| The Catholic University of Korea Seoul ST.MARY'S Hospital | Seoul | South Korea | 1 |
| Yonsei University Severance Hospital | Seoul | South Korea | 4 |